Dr. Theodore J. Witek, Jr., also known as Ted, served as Chief Executive Officer and President of Boehringer Ingelheim (Canada) Ltd./Ltée. Dr. Witek was President and Chief Executive Officer of Boehringer Ingelheim (Canada) Ltd. since 2008 and was Head of the Prescription Medicine business. Dr. Witek served as Managing Director, Boehringer Ingelheim Portugal. During his tenure with Boehringer Ingelheim beginning in 1983 he held various clinical research positions, including Director of Respiratory and Immunology Clinical Research. Dr. Witek served on the Board of Directors of Canada's Research-Based Pharmaceutical Companies (Rx&D) and was the Chair of the Health Technology Assessment Committee. Dr. Witek is a Member of CEO Advisory Board of Lumira Capital Corp. He was appointed to the Ontario Health Innovation Council and is an Associate Professor at the University of Toronto's Leslie Dan Faculty of Pharmacy. Dr. Witek is the author of more than 100 scientific papers as well as several chapters and books. Dr. Witek holds an M.B.A. from Henley Management College in the UK, a Doctor of Public Health from Columbia University and a Master of Public Health from Yale University.